683 Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2M | Buy |
2,105,000
+660,000
| +46% | +$6.33M | 1.33% | 11 |
|
|
2025
Q1 | $9.06M | Buy |
1,445,000
+420,000
| +41% | +$2.63M | 0.62% | 38 |
|
|
2024
Q4 | $8.32M | Buy |
1,025,000
+15,000
| +1% | +$122K | 0.52% | 41 |
|
|
2024
Q3 | $18.3M | Sell |
1,010,000
-390,000
| -28% | -$7.05M | 1.39% | 19 |
|
|
2024
Q2 | $14.4M | Sell |
1,400,000
-250,000
| -15% | -$2.58M | 1.09% | 24 |
|
|
2024
Q1 | $17.5M | Buy |
1,650,000
+370,000
| +29% | +$3.93M | 1.28% | 22 |
|
|
2023
Q4 | $11.7M | Buy |
1,280,000
+180,000
| +16% | +$1.64M | 0.96% | 35 |
|
|
2023
Q3 | $11.4M | Sell |
1,100,000
-187,500
| -15% | -$1.94M | 0.89% | 31 |
|
|
2023
Q2 | $18.4M | Sell |
1,287,500
-38,000
| -3% | -$544K | 1.32% | 19 |
|
|
2023
Q1 | $9.46M | Sell |
1,325,500
-24,500
| -2% | -$175K | 0.7% | 36 |
|
|
2022
Q4 | $15.1M | Sell |
1,350,000
-313,943
| -19% | -$3.52M | 1.28% | 20 |
|
|
2022
Q3 | $18.4M | Buy |
1,663,943
+223,943
| +16% | +$2.48M | 1.42% | 22 |
|
|
2022
Q2 | $12.2M | Buy |
1,440,000
+1,085,000
| +306% | +$9.16M | 0.86% | 35 |
|
|
2022
Q1 | $4.83M | Buy |
355,000
+64,405
| +22% | +$877K | 0.26% | 75 |
|
|
2021
Q4 | $5.72M | Buy |
+290,595
| New | +$5.72M | 0.21% | 75 |
|